Proteomic profiling further identified the enrichment of SPPL2A in the melanoma exosomal cargo (a molecule previously correlated with diminished disease-free and overall survival) suggesting its potential utility as a prognostic indicator within the extracellular vesicle compartment. This evidence concerns the gene SPPL2A and melanoma.